Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis.

about

Comparative study on individual aromatase inhibitors on cardiovascular safety profile: misleading analysis and doubtful methodology.

P2860

Q36326009-AA4A1E3E-3D6C-416F-AB88-454A1E16051F

P2860

Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis.

Item

http://www.wikidata.org/entity/Q36140045

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Comparative study on individua ...... file: a network meta-analysis.

@ast

Comparative study on individua ...... file: a network meta-analysis.

@en

type

Item

label

Comparative study on individua ...... file: a network meta-analysis.

@ast

Comparative study on individua ...... file: a network meta-analysis.

@en

prefLabel

Comparative study on individua ...... file: a network meta-analysis.

@ast

Comparative study on individua ...... file: a network meta-analysis.

@en

P1476

Comparative study on individua ...... file: a network meta-analysis.

@en

P2093

Huawei Zou

http://www.w3.org/2001/XMLSchema#string

Kai Li

http://www.w3.org/2001/XMLSchema#string

Lei Liu

http://www.w3.org/2001/XMLSchema#string

Li Zhao

http://www.w3.org/2001/XMLSchema#string

Wusheng Li

http://www.w3.org/2001/XMLSchema#string

Xihe Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1.

Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)--a randomised controlled trial of exemestane versus continued tamoxifen after 2-3 years tamoxifen.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

A decade of letrozole: FACE

Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer.

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial

Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.

P304

2721-2730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S88179

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26491345

http://www.w3.org/2001/XMLSchema#string

P932

4599049

http://www.w3.org/2001/XMLSchema#string

Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis.

about

P2860

P2860

Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932